Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 16 results
Filters: First Letter Of Title is F  [Clear All Filters]
Found 16 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

F

Zheng L, Taiwo B, Gandhi RT, et al. "Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy." J. Acquir. Immune Defic. Syndr.. 2014;67(2):153-60.
Andersen JW, Fass R, van der Horst C. "Factors associated with early study discontinuation in AACTG studies, DACS 200." Contemp Clin Trials. 2007;28(5):583-92.
Smurzynski M, Wu K, Schouten JT, et al. "Factors associated with remaining on initial randomized efavirenz-containing regimens." AIDS. 2013;27(12):1887-97.
Li JZ, Brumme ZL, Brumme CJ, et al. "Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial." J. Infect. Dis.. 2011;203(7):976-83.
Brehm JH, Lalama CM, Hughes MD, et al. "Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase." J. Acquir. Immune Defic. Syndr.. 2011;56(4):344-8.
Sharif M, Daryani A, Karimi SA. "A faunistic survey of cercariae isolated from lymnaeid snails in central areas of Mazandaran, Iran." Pak. J. Biol. Sci.. 2010;13(4):158-63.
McLaren PJ, Ripke S, Pelak K, et al. "Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans." Hum. Mol. Genet.. 2012;21(19):4334-47.
Ciaranello AL, Lockman S, Freedberg KA, et al. "First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial." AIDS. 2011;25(4):479-92.
Gerber JG, Kitch DW, Fichtenbaum CJ, et al. "Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186." J. Acquir. Immune Defic. Syndr.. 2008;47(4):459-66.
Yin MT, Kendall MA, Wu X, et al. "Fractures after antiretroviral initiation." AIDS. 2012;26(17):2175-84.
Kendall MA, Tassiopoulos K, McComsey GA, Yin MT. "Fractures Are Not Associated with CD8(+) T Cell Activation: An Analysis of the ACTG ALLRT Study." AIDS Res. Hum. Retroviruses. 2015;31(8):769-71.
Kelly SG, Wu K, Tassiopoulos K, Erlandson KM, Koletar SL, Palella FJ. "Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease and diabetes among aging adults with HIV." Clin. Infect. Dis.. 2018.
Tassiopoulos K, Abdo M, Wu K, et al. "Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults." AIDS. 2017;31(16):2287-2294.
Erlandson KM, Perez J, Abdo M, et al. "Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus." Clin. Infect. Dis.. 2019;68(1):131-138.
Hitti J, Halvas EK, Zheng L, et al. "Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207." J AIDS Clin Res. 2014;5(11).
Skinner-Adams TS, Butterworth AS, Porter KA, et al. "The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment." PLoS ONE. 2012;7(4):e34399.